Learning Objectives:

1. Ablation and radiation segmentectomy are curative intent therapies for early stage HCC

2. Goal of neoadjuvant local regional therapy for HCC is complete pathologic necrosis 

3. HCC tumor size and location drive therapy selection and outcomes

Session date: 
09/27/2023 - 7:30am to 8:15am CDT
Add to calendar: 
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Participation

Please login or create an account to proceed.
Speaker Name: 
Christopher Molvar, MD